UNITS PLUMMETS AFTER NOVO NORDISK DEAL FAILURE

Shares of HIMS experienced a dramatic drop today following the unexpected termination of its deal with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending the company's stock price plummeting by nearly 20%. The reason for the breakdown of the partnership remains unclear, but industry analysts speculate that it c